BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3704 related articles for article (PubMed ID: 19031184)

  • 21. Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T.
    Rosenkrantz AB; Kim S; Campbell N; Gaing B; Deng FM; Taneja SS
    AJR Am J Roentgenol; 2015 Mar; 204(3):W266-72. PubMed ID: 25714311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
    Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
    J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of diffusion-weighted magnetic resonance imaging and contrast-enhanced harmonic ultrasonography in detection and location of prostate transition-zone cancer.
    Wang R; Chen JJ; Zhou YC; Huang MM; Zhang XR; Miao HD
    J Int Med Res; 2011; 39(1):256-66. PubMed ID: 21672329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging.
    Tamada T; Sone T; Higashi H; Jo Y; Yamamoto A; Kanki A; Ito K
    AJR Am J Roentgenol; 2011 Sep; 197(3):664-70. PubMed ID: 21862809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benign prostatic hyperplasia: evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI.
    Kershaw LE; Hutchinson CE; Buckley DL
    J Magn Reson Imaging; 2009 Mar; 29(3):641-8. PubMed ID: 19243046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gadolinium-enhanced three-dimensional magnetization-prepared rapid gradient-echo (3D MP-RAGE) imaging is superior to spin-echo imaging in delineating brain metastases.
    Takeda T; Takeda A; Nagaoka T; Kunieda E; Takemasa K; Watanabe M; Hatou T; Oguro S; Katayama M
    Acta Radiol; 2008 Dec; 49(10):1167-73. PubMed ID: 18979271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis.
    Tamada T; Sone T; Jo Y; Yamamoto A; Yamashita T; Egashira N; Imai S; Fukunaga M
    Radiology; 2008 Aug; 248(2):531-9. PubMed ID: 18539890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy.
    Roy C; Foudi F; Charton J; Jung M; Lang H; Saussine C; Jacqmin D
    AJR Am J Roentgenol; 2013 Apr; 200(4):W361-8. PubMed ID: 23521479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging.
    Delongchamps NB; Rouanne M; Flam T; Beuvon F; Liberatore M; Zerbib M; Cornud F
    BJU Int; 2011 May; 107(9):1411-8. PubMed ID: 21044250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).
    Panebianco V; Sciarra A; Lisi D; Galati F; Buonocore V; Catalano C; Gentile V; Laghi A; Passariello R
    Eur J Radiol; 2012 Apr; 81(4):700-8. PubMed ID: 21330082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy.
    Sciarra A; Panebianco V; Ciccariello M; Salciccia S; Cattarino S; Lisi D; Gentilucci A; Alfarone A; Bernardo S; Passariello R; Gentile V
    Clin Cancer Res; 2010 Mar; 16(6):1875-83. PubMed ID: 20197480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
    Franiel T; Lüdemann L; Rudolph B; Rehbein H; Staack A; Taupitz M; Prochnow D; Beyersdorff D
    Invest Radiol; 2008 Jul; 43(7):481-7. PubMed ID: 18580330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
    Gemeinhardt O; Lüdemann L; Prochnow D; Abramjuk C; Taupitz M; Hamm B; Beyersdorff D
    Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (Xu PJ; Yan FH; Wang JH; Lin J; Ji Y; Chen CZ; Shen JZ; Li RC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):592-6. PubMed ID: 19595157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone.
    Li H; Sugimura K; Kaji Y; Kitamura Y; Fujii M; Hara I; Tachibana M
    AJR Am J Roentgenol; 2006 Mar; 186(3):729-42. PubMed ID: 16498100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer: Comparison of 3D T2-weighted with conventional 2D T2-weighted imaging for image quality and tumor detection.
    Rosenkrantz AB; Neil J; Kong X; Melamed J; Babb JS; Taneja SS; Taouli B
    AJR Am J Roentgenol; 2010 Feb; 194(2):446-52. PubMed ID: 20093608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Endorectal magnetic resonance imaging for staging of prostatic cancer].
    Hayashi N; Kawamura J; Sugimura Y
    Hinyokika Kiyo; 1996 Oct; 42(10):767-73. PubMed ID: 8951473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 186.